Baxter Pre-Tax Income 2010-2024 | BAX
Baxter annual/quarterly pre-tax income history and growth rate from 2010 to 2024. Pre-tax income can be defined as company's earnings or loss before taxes on income have been accounted for.
- Baxter pre-tax income for the quarter ending December 31, 2024 was $-0.217B, a 162.54% decline year-over-year.
- Baxter pre-tax income for the twelve months ending December 31, 2024 was $-0.289B, a 219.42% decline year-over-year.
- Baxter annual pre-tax income for 2024 was $-0.289B, a 219.42% decline from 2023.
- Baxter annual pre-tax income for 2023 was $0.242B, a 107.45% decline from 2022.
- Baxter annual pre-tax income for 2022 was $-3.248B, a 391.04% decline from 2021.
| Baxter Annual Pre-Tax Income (Millions of US $) |
|
|---|---|
| 2024 | $-289 |
| 2023 | $242 |
| 2022 | $-3,248 |
| 2021 | $1,116 |
| 2020 | $1,292 |
| 2019 | $970 |
| 2018 | $1,617 |
| 2017 | $1,100 |
| 2016 | $4,954 |
| 2015 | $428 |
| 2014 | $490 |
| 2013 | $375 |
| 2012 | $2,838 |
| 2011 | $2,809 |
| 2010 | $1,890 |
| 2009 | $2,734 |
| Baxter Quarterly Pre-Tax Income (Millions of US $) |
|
|---|---|
| 2024-12-31 | $-217 |
| 2024-09-30 | $69 |
| 2024-06-30 | $-257 |
| 2024-03-31 | $116 |
| 2023-12-31 | $347 |
| 2023-09-30 | $64 |
| 2023-06-30 | $-183 |
| 2023-03-31 | $14 |
| 2022-12-31 | $-516 |
| 2022-09-30 | $-3,045 |
| 2022-06-30 | $219 |
| 2022-03-31 | $94 |
| 2021-12-31 | $-78 |
| 2021-09-30 | $451 |
| 2021-06-30 | $392 |
| 2021-03-31 | $351 |
| 2020-12-31 | $210 |
| 2020-09-30 | $415 |
| 2020-06-30 | $289 |
| 2020-03-31 | $378 |
| 2019-12-31 | $-223 |
| 2019-09-30 | $481 |
| 2019-06-30 | $326 |
| 2019-03-31 | $386 |
| 2018-12-31 | $403 |
| 2018-09-30 | $372 |
| 2018-06-30 | $404 |
| 2018-03-31 | $438 |
| 2017-12-31 | $176 |
| 2017-09-30 | $290 |
| 2017-06-30 | $306 |
| 2017-03-31 | $328 |
| 2016-12-31 | $279 |
| 2016-09-30 | $128 |
| 2016-06-30 | $1,218 |
| 2016-03-31 | $3,329 |
| 2015-12-31 | $205 |
| 2015-09-30 | $-33 |
| 2015-06-30 | $108 |
| 2015-03-31 | $148 |
| 2014-12-31 | $109 |
| 2014-09-30 | $202 |
| 2014-06-30 | $602 |
| 2014-03-31 | $653 |
| 2013-12-31 | $524 |
| 2013-09-30 | $664 |
| 2013-06-30 | $743 |
| 2013-03-31 | $693 |
| 2012-12-31 | $523 |
| 2012-09-30 | $766 |
| 2012-06-30 | $817 |
| 2012-03-31 | $732 |
| 2011-12-31 | $548 |
| 2011-09-30 | $727 |
| 2011-06-30 | $803 |
| 2011-03-31 | $731 |
| 2010-12-31 | $467 |
| 2010-09-30 | $641 |
| 2010-06-30 | $670 |
| 2010-03-31 | $112 |
| 2009-12-31 | $715 |
| 2009-09-30 | $658 |
| 2009-06-30 | $724 |
| 2009-03-31 | $637 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $15.608B | $10.636B |
| Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $230.702B | 27.74 |
| Boston Scientific (BSX) | United States | $154.217B | 38.61 |
| Stryker (SYK) | United States | $145.561B | 30.44 |
| EssilorLuxottica (ESLOY) | France | $133.244B | 0.00 |
| Medtronic (MDT) | Ireland | $107.028B | 15.63 |
| Lonza Group Ag (LZAGY) | Switzerland | $52.631B | 0.00 |
| Haleon (HLN) | United Kingdom | $47.943B | 27.26 |
| ResMed (RMD) | United States | $35.287B | 26.50 |
| GE HealthCare Technologies (GEHC) | United States | $31.763B | 15.08 |
| Agilent Technologies (A) | United States | $30.897B | 20.41 |
| Terumo (TRUMY) | Japan | $29.152B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $24.100B | 17.21 |
| Insulet (PODD) | United States | $18.209B | 77.71 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.901B | 11.50 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.425B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $7.970B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $7.395B | 18.18 |
| Bio-Rad Laboratories (BIO) | United States | $6.728B | 22.75 |
| Prestige Consumer Healthcare (PBH) | United States | $4.111B | 19.62 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Perrigo (PRGO) | Ireland | $3.444B | 9.86 |
| ICU Medical (ICUI) | United States | $3.347B | 28.51 |
| Haemonetics (HAE) | United States | $3.139B | 14.77 |
| Envista Holdings (NVST) | United States | $2.876B | 23.90 |
| GN Store Nord (GNNDY) | Denmark | $2.071B | 17.15 |
| QuidelOrtho (QDEL) | United States | $1.868B | 15.64 |
| LeMaitre Vascular (LMAT) | United States | $1.817B | 40.63 |
| AtriCure (ATRC) | United States | $1.439B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.359B | 21.40 |
| Neogen (NEOG) | United States | $1.224B | 15.67 |
| AdaptHealth (AHCO) | United States | $1.173B | 11.30 |
| Kestra Medical Technologies (KMTS) | United States | $1.159B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.150B | 0.00 |
| InMode (INMD) | Israel | $0.991B | 9.08 |
| Phibro Animal Health (PAHC) | United States | $0.791B | 12.13 |
| Evolus (EOLS) | United States | $0.774B | 0.00 |
| Owens & Minor (OMI) | United States | $0.632B | 5.38 |
| Curaleaf Holdings (CURLF) | Canada | $0.618B | 0.00 |
| CeriBell (CBLL) | United States | $0.583B | 0.00 |
| Valneva SE (VALN) | France | $0.557B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.539B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.470B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.442B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.437B | 0.00 |
| Omeros (OMER) | United States | $0.397B | 0.00 |
| Surmodics (SRDX) | United States | $0.386B | 0.00 |
| SNDL (SNDL) | Canada | $0.355B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.348B | 15.09 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.312B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.290B | 26.18 |
| Sanara MedTech (SMTI) | United States | $0.288B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.265B | 47.20 |
| Sanuwave Health (SNWV) | United States | $0.265B | 0.00 |
| Cerus (CERS) | United States | $0.249B | 0.00 |
| ZimVie (ZIMV) | United States | $0.247B | 14.80 |
| Canopy Growth (CGC) | Canada | $0.234B | 0.00 |
| Quanterix (QTRX) | United States | $0.225B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.221B | 0.00 |
| High Tide (HITI) | Canada | $0.192B | 0.00 |
| Biote (BTMD) | United States | $0.178B | 4.06 |
| Utah Medical Products (UTMD) | United States | $0.172B | 13.83 |
| TriSalus Life Sciences (TLSI) | United States | $0.165B | 0.00 |
| Brainsway (BWAY) | Israel | $0.164B | 51.24 |
| Organigram Global (OGI) | Canada | $0.149B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.145B | 17.91 |
| Jin Medical (ZJYL) | China | $0.125B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.118B | 0.00 |
| Exagen (XGN) | United States | $0.113B | 0.00 |
| Agape ATP (ATPC) | $0.105B | 0.00 | |
| MacroGenics (MGNX) | United States | $0.103B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.094B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.093B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.081B | 0.00 |
| Fonar (FONR) | United States | $0.076B | 10.61 |
| Veru (VERU) | United States | $0.075B | 0.00 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| Zynex (ZYXI) | United States | $0.064B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.057B | 0.00 |
| United Health Products (UEEC) | United States | $0.057B | 0.00 |
| ImmuCell (ICCC) | United States | $0.047B | 0.00 |
| Apyx Medical (APYX) | United States | $0.044B | 0.00 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.041B | 59.50 |
| Safety Shot (SHOT) | United States | $0.038B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 11.31 |
| Nephros (NEPH) | United States | $0.020B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |